nieuws



Breast cancer risk varies among different progestins used in hormone replacement therapy

 

Dr. Salman Hyder has found that progestins used in hormone replacement therapies to counteract the negative effects of estrogen on the uterus and reduce the risk of uterine cancer may increase the risk of breast cancer.

Link


[ Terug naar het hoofdmenu ]